Literature DB >> 3156701

Chronic myelocytic leukaemia: HLA association and decreased erythrocyte C3b receptor expression.

P Ruuska, S Silvennoinen-Kassinen, T Timonen, A Tiilikainen.   

Abstract

A series of 27 adult patients with chronic myelocytic leukaemia (CML) were examined for erythrocyte C3b receptor (EC3bR) expression. Twenty-five patients were successfully HLA typed and there was a positive association of CML with HLA-B40 (P less than 0.01). Only 10 (37%) of the patients were EC3bR positive (P less than 0.00001) compared to 223 healthy controls of whom 198 (89%) were EC3bR positive. The positivity of EC3bR and HLA-B40 occurred simultaneously in six patients (P less than 0.05). HLA-B40 positivity and EC3bR expression were correlated with the following variables: age at the time of CML diagnoses, duration of CML (until death or the end of follow-up period 1 July 1983), the stage of CML and simultaneous medication. EC3bR positive patients were significantly more often in remission (P less than 0.05) and also had shorter duration of the disease (P less than 0.005) then did EC3bR negative ones. No significant correlation existed between EC3bR status and the other parameters. The presence of HLA-B40 did not associate with any of the listed variables. These findings may indicate the loss of the receptor in the course of CML with increasing immaturity of cells released from bone marrow.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156701      PMCID: PMC1577125     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Stimulatory and cytotoxic activity on human adult and fetal lymphocytes by heterologous antihuman fetal lymphocyte sera.

Authors:  O Turunen; C Lundqvist; M Julin; G Holmlund; A Tiilikainen; A de la Chapelle
Journal:  Transplantation       Date:  1979-05       Impact factor: 4.939

2.  Evaluation of linkage of the human C3b/C4b receptor to HLA.

Authors:  J A Hatch; J P Atkinson; B K Suarez; T R Dykman
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

3.  Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus.

Authors:  Y Miyakawa; A Yamada; K Kosaka; F Tsuda; E Kosugi; M Mayumi
Journal:  Lancet       Date:  1981-09-05       Impact factor: 79.321

4.  Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).

Authors:  S Tsuchiya; M Yamabe; Y Yamaguchi; Y Kobayashi; T Konno; K Tada
Journal:  Int J Cancer       Date:  1980-08       Impact factor: 7.396

5.  HLA haplotypes and long survival in childhood acute lymphoblastic leukaemia treated with transfer factor.

Authors:  M De Bruyère; G Cornu; T Heremans-Bracke; J Malchaire; G Sokal
Journal:  Br J Haematol       Date:  1980-02       Impact factor: 6.998

6.  HLA antigens in rubella seronegative young adults.

Authors:  J Ilonen; A C Anttila; M Lehtinen; K Hakkarainen; M Pietiläinen; A Tiilikainen; P Leinikki
Journal:  Tissue Antigens       Date:  1983-11

7.  Distribution of complement receptors on human normal and malignant mononuclear cells.

Authors:  R B Slease; J E Gadek; M M Frank; I Scher
Journal:  Blood       Date:  1980-11       Impact factor: 22.113

8.  Frequency of HLA antigens in chronic myelocytic leukemia.

Authors:  J P Hester; R Rossen; J Trujillo; K B McCredie; E J Freireich
Journal:  South Med J       Date:  1977-06       Impact factor: 0.954

9.  HLA antigens and childhood acute lymphocytic leukaemia.

Authors:  F R Davey; N A Lachant; N L Dock; C Hubbell; J A Stockman; J B Henry
Journal:  Br J Haematol       Date:  1981-02       Impact factor: 6.998

10.  Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage.

Authors:  P J Fialkow; R J Jacobson; T Papayannopoulou
Journal:  Am J Med       Date:  1977-07       Impact factor: 4.965

View more
  2 in total

1.  HLA-DR genotyping by restriction fragment length polymorphism analyses.

Authors:  K Hui; H Festenstein; A de Klein; G Grosveld; F Grosveld
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?

Authors:  P E Ruuska; I Ikäheimo; S Silvennoinen-Kassinen; M L Käär; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.